Cancer – Page 5 – HealthQuill

US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.

by HealthQuill
April 17, 2023
0 Comments

Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid tumors.

Drugs Health Pharma

Canada’s Fusion gets FDA nod for drug tests to treat solid tumors

HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid.

by HealthQuill
April 13, 2023
0 Comments

U.S. Bankruptcy Court for the District of New Jersey

Drugs Health Medical Pharma

J&J raises talc settlement to $8.9 billion, unit files for a second bankruptcy

HQ Team April 5, 2023: Johnson and Johnson, a US multinational making pharmaceuticals and medical devices, has offered to pay $8.9 billion to.

by HealthQuill
April 5, 2023
0 Comments

BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer antibody drug candidates.

Drugs Medical Pharma

BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs

HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.

by HealthQuill
April 3, 2023
0 Comments

The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories, after Yemen and Lebanon raised concerns.

Drugs Medical Pharma

Yemen, Lebanon allege India’s Celon Labs’ drug ‘substandard’

The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.

by HealthQuill
March 28, 2023
0 Comments

BioNTech, a Germany-based biotechnology company, is expected to spend between 2.4 million euros and 2.6 million euros on research this year compared with 1.5 million euros last year.

Drugs Medical Pharma

BioNTech in one million euro push for research on drugs

BioNTech, a Germany-based biotechnology company, is expected to spend between 2.4 million euros and 2.6 million euros on research this year compared with.

by HealthQuill
March 27, 2023
0 Comments

Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in the US sites for its drug to treat advanced solid tumours and lymphomas.

Drugs Medical Pharma

Glenmark gets FDA nod for trials in US on tumour, cancer patients

Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in.